FREEHOLD, NJ -- (Marketwired) -- 11/21/16 -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst", a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device would like to update its shareholders on its progress in the international market. The Company has previously announced that it has met with medical representatives and buyers in Dubai, Saudi Arabia, Kuwait, Qatar, Morocco and Spain. Medifirst is pleased to announce that it has been asked to bring its medical staff to Morocco and Dubai to demonstrate its laser technology as part of finalizing its first international sales orders. The Company is optimistic that it will have firm commitments for bulk orders once the demonstrations are completed.
Commented CEO Bruce J. Schoengood, "We are thrilled with the response to our lasers by the international community and we are excited to complete the demonstrations, meet our new vendors, complete and fulfill our purchase orders and finalize our new distribution agreements. We are eager to have our Medical Director and staff show how effective our lasers are in reducing pain." The Company has scheduled the demonstrations in January and anticipates that it will, as previously announced, begin booking sales in Q1 2017. Continued Schoengood, "As we continue to set up international operations, we will also be training licensed technicians to use the laser so as to expedite sales in the Mid-East, Spain and Africa."
(0)
(0)
Medifirst Solutions Inc. (MFST) Stock Research Links